Chronic benzodiazepine treatment triggers gephyrin scaffold destabilization and GABAAR subsynaptic reorganization.

IF 4 3区 医学 Q2 NEUROSCIENCES
Frontiers in Cellular Neuroscience Pub Date : 2025-07-04 eCollection Date: 2025-01-01 DOI:10.3389/fncel.2025.1624813
Caitlyn A Chapman, Nadya Povysheva, Tyler B Tarr, Jessica L Nuwer, Stephen D Meriney, Jon W Johnson, Tija C Jacob
{"title":"Chronic benzodiazepine treatment triggers gephyrin scaffold destabilization and GABA<sub>A</sub>R subsynaptic reorganization.","authors":"Caitlyn A Chapman, Nadya Povysheva, Tyler B Tarr, Jessica L Nuwer, Stephen D Meriney, Jon W Johnson, Tija C Jacob","doi":"10.3389/fncel.2025.1624813","DOIUrl":null,"url":null,"abstract":"<p><p>Benzodiazepines (BZDs) are important clinical drugs with anxiolytic, anticonvulsant, and sedative effects mediated by potentiation of inhibitory GABA type A receptors (GABA<sub>A</sub>Rs). Tolerance limits the clinical utility of BZDs, yet the mechanisms underlying tolerance after chronic exposure have not been thoroughly investigated. Here, we assessed the impact of chronic (7-day) treatment with the BZD diazepam (DZP) on the dynamic plasticity and subsynaptic organization of the gephyrin scaffold and γ2 subunit-containing GABA<sub>A</sub>Rs in primary neurons. After functional confirmation of diminished BZD sensitivity, we provide the first super-resolution analysis of inhibitory nanoscale plasticity induced by chronic BZD exposure: gephyrin subsynaptic domains were smaller and the inhibitory postsynaptic area was overall diminished by DZP treatment, resulting in a condensation of synaptic γ2-GABA<sub>A</sub>Rs into smaller synaptic areas. Using a novel fluorescence-based <i>in situ</i> proximity ligation assay and biochemical fractionation analysis, the mechanism for gephyrin downregulation was revealed to be dependent on phosphorylation and protease cleavage. Accordingly, DZP treatment impaired gephyrin synaptic stability, demonstrated by live-imaging photobleaching experiments. Despite the loss of BZD sensitivity and stable synaptic gephyrin, 7-day DZP treatment did not reduce the surface or total protein levels of BZD-sensitive γ2-GABA<sub>A</sub>Rs, as shown in prior short-term BZD treatment studies. Instead, chronic DZP treatment induced an accumulation of γ2-GABA<sub>A</sub>Rs in the extrasynaptic membrane. Surprisingly, γ2-GABA<sub>A</sub>R interactions with gephyrin were also enriched extrasynaptically. An identified rise in extrasynaptically-localized gephyrin cleavage fragments may function to confine receptors away from the synapse, as supported by a decrease in extrasynaptic γ2-GABA<sub>A</sub>R mobility. Altogether, we find that chronic BZD treatment triggers several subtle converging plasticity events at inhibitory synapses which effectively restrict the synaptic renewal of BZD-sensitive GABA<sub>A</sub>Rs via mechanisms distinct from those observed with short-term treatment.</p>","PeriodicalId":12432,"journal":{"name":"Frontiers in Cellular Neuroscience","volume":"19 ","pages":"1624813"},"PeriodicalIF":4.0000,"publicationDate":"2025-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12271172/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Cellular Neuroscience","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fncel.2025.1624813","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

Benzodiazepines (BZDs) are important clinical drugs with anxiolytic, anticonvulsant, and sedative effects mediated by potentiation of inhibitory GABA type A receptors (GABAARs). Tolerance limits the clinical utility of BZDs, yet the mechanisms underlying tolerance after chronic exposure have not been thoroughly investigated. Here, we assessed the impact of chronic (7-day) treatment with the BZD diazepam (DZP) on the dynamic plasticity and subsynaptic organization of the gephyrin scaffold and γ2 subunit-containing GABAARs in primary neurons. After functional confirmation of diminished BZD sensitivity, we provide the first super-resolution analysis of inhibitory nanoscale plasticity induced by chronic BZD exposure: gephyrin subsynaptic domains were smaller and the inhibitory postsynaptic area was overall diminished by DZP treatment, resulting in a condensation of synaptic γ2-GABAARs into smaller synaptic areas. Using a novel fluorescence-based in situ proximity ligation assay and biochemical fractionation analysis, the mechanism for gephyrin downregulation was revealed to be dependent on phosphorylation and protease cleavage. Accordingly, DZP treatment impaired gephyrin synaptic stability, demonstrated by live-imaging photobleaching experiments. Despite the loss of BZD sensitivity and stable synaptic gephyrin, 7-day DZP treatment did not reduce the surface or total protein levels of BZD-sensitive γ2-GABAARs, as shown in prior short-term BZD treatment studies. Instead, chronic DZP treatment induced an accumulation of γ2-GABAARs in the extrasynaptic membrane. Surprisingly, γ2-GABAAR interactions with gephyrin were also enriched extrasynaptically. An identified rise in extrasynaptically-localized gephyrin cleavage fragments may function to confine receptors away from the synapse, as supported by a decrease in extrasynaptic γ2-GABAAR mobility. Altogether, we find that chronic BZD treatment triggers several subtle converging plasticity events at inhibitory synapses which effectively restrict the synaptic renewal of BZD-sensitive GABAARs via mechanisms distinct from those observed with short-term treatment.

慢性苯二氮卓类药物治疗触发格啉支架不稳定和GABAAR突触亚重组。
苯二氮卓类药物是一种重要的抗焦虑、抗惊厥和镇静作用的临床药物,其作用机制是抑制性GABAA型受体(GABAARs)的增强。耐受性限制了BZDs的临床应用,但慢性暴露后耐受性的机制尚未得到彻底研究。在这里,我们评估了慢性(7天)用BZD地西安定(DZP)治疗对初级神经元中卟啉支架和含γ - 2亚单位的GABAARs的动态可塑性和亚突触组织的影响。在功能性确认BZD敏感性降低后,我们首次对慢性BZD暴露诱导的抑制性纳米尺度可塑性进行了超分辨率分析:DZP处理导致gephyrin亚突触区域变小,抑制性突触后区域整体减少,导致突触γ - 2- gabaars缩聚到更小的突触区域。利用一种新的基于荧光的原位邻近连接实验和生化分离分析,揭示了gephyrin下调的机制依赖于磷酸化和蛋白酶裂解。因此,DZP处理破坏了酞菁突触的稳定性,这一点在实时成像光漂白实验中得到了证实。尽管失去了BZD的敏感性和稳定的突触卟啉,7天的DZP治疗并没有降低BZD敏感的γ - 2- gabaars的表面或总蛋白水平,这在之前的短期BZD治疗研究中得到了证实。相反,慢性DZP处理诱导突触外膜中γ - 2- gabaars的积累。令人惊讶的是,γ - 2- gabaar与gephyrin的相互作用也在胞外富集。在突触外定位的卟啉裂解片段的增加可能会限制受体远离突触,这是由突触外γ - 2- gabaar迁移的减少所支持的。总之,我们发现慢性BZD治疗在抑制性突触触发了一些微妙的趋同可塑性事件,这些事件通过与短期治疗不同的机制有效地限制了BZD敏感GABAARs的突触更新。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
7.90
自引率
3.80%
发文量
627
审稿时长
6-12 weeks
期刊介绍: Frontiers in Cellular Neuroscience is a leading journal in its field, publishing rigorously peer-reviewed research that advances our understanding of the cellular mechanisms underlying cell function in the nervous system across all species. Specialty Chief Editors Egidio D‘Angelo at the University of Pavia and Christian Hansel at the University of Chicago are supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信